By Ricky Zipp writing for MedTechDive July 2021, “Dexcom wins FDA nod for real-time artificial pancreas systems (APIs), allowing third-party developers access to CGM data of Dexcom users. Dexcom contends that the APIs will help patients and healthcare providers as both treatment information and patient-specific CGM information will be in one place and allow for ‘in-the-moment’ diabetes management coaching and feedback. Developers can integrate CGM data with their applications, diabetes management systems or devices through the new APIs, according to the announcement. Diabetes management companies like Teladoc Health’s Livongo for Diabetes and the smartwatch maker Garmin are in the testing and development phase of syncing their products with Dexcom users’ sensor data.
To read more CLICK HERE.
